Skip to content
Screener

Scholar Rock SRRK Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$1.01M-47.3%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$4.11M+77.9%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$1.37M+180%

Other financials

Income statement

See full
Revenue-
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.44B+113%
Enterprise value$6.21B+112%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Amortization of debt discount and debt issuance costs143462
Loss on disposal of property and equipment3
Equity-based compensation37,90737,846
Accretion of investment securities(305)(3,296)
Non-cash operating lease expense3,0592,533
Loss on extinguishment of debt3,337
Unrealized foreign currency exchange rate losses1,253
Change in operating assets and liabilities:

Item 1. Financial Statements

FAQ

What is Scholar Rock's accretion (amortization) of discounts and premiums, investments?
Scholar Rock (SRRK) reported accretion (amortization) of discounts and premiums, investments of $136K in Q2 2026.
How has Scholar Rock's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Scholar Rock's accretion (amortization) of discounts and premiums, investments decreased by 90.2% year-over-year, from $1.39M to $136K.
What is the long-term trend for Scholar Rock's accretion (amortization) of discounts and premiums, investments?
Over 4 years (2021 to 2025), Scholar Rock's accretion (amortization) of discounts and premiums, investments has grown at a 44.4% compound annual growth rate (CAGR), from -$918K to $3.99M.
What does accretion (amortization) of discounts and premiums, investments mean?
This metric represents the non-cash adjustment to the carrying value of investment securities held by the company. It reflects the systematic recognition of discounts or premiums over the life of the investment to align the book value with the effective interest rate. This adjustment is essential for reconciling net income with cash flow from operations as it accounts for changes in investment value that do not involve immediate cash movement.

Ask your AI about Scholar Rock's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude